The eosinophil-associated ribonuclease (Ear) family in the mouse major effector cells responsible for the pathologies associconsists of thirteen genes, eleven of which encode RNases that ated with allergic inflammatory diseases (10, 11). However, have physical/functional properties similar to the human Ears, the mechanisms by which these individual effector cells eosinophil-derived neurotoxin and eosinophil cationic protein.
that a major homeostatic function of the eosinophil is to defend against large nonphagocytosable targets that often The onset and progression of allergic asthma is accompanied escape the specific killing mechanisms associated with B by a complex series of overlapping, and often concurrent, and T cells (e.g., helminthic larvae and protozoan parasites inflammatory responses in the lung that are orchestrated by [14] [15] [16] [17] ). Although several independent eosinophil effector CD4 ϩ T H 2 lymphocytes (1-5) and the expression of T H 2 functions are likely to contribute to allergen-mediated proinflammatory cytokines (e.g., interleukin [IL]-4, -5, and changes in the lung (e.g., release of leukotrienes [18] , secre--13 [6] [7] [8] ). This inflammation is characterized by cellular tion of immunoregulative cytokines [19] , generation of reacinfiltrates that are, in part, thought to be the underlying tive oxygen species [20, 21] ), the release of a diverse group cause(s) of the accompanying airway obstruction and lung of proteins sequestered in eosinophil secondary granules dysfunction. In particular, the differential recruitment of (i.e., degranulation) has been highlighted as an important eosinophils to the airway mucosa and lumen are common effector function. features of allergic respiratory disease, occurring in Ͼ 75%
One of the groups of proteins identified in the secondary of reported cases (9) . Considerable evidence has amassed granule is the eosinophil-associated RNases (Ears) (22-25). in patients, as well as animal models, suggesting that eosino-
In particular, studies of the human Ears, eosinophil-derived phils and CD4 ϩ T lymphocytes play an integral role as the neurotoxin (EDN), and eosinophil cationic protein (ECP), showed that they potentiate innate mechanisms capable of targeting specific pathogens. Micromolar concentrations of in saline for 20 min on Days 24, 25, and 26 using an ultrasonic sequence of innate defense mechanisms that potentially nebulizer (DeVilbiss, Somerset, PA). All assays were performed provide a molecular/cellular link between respiratory viral on Day 28. Control saline-treated animals were injected intraperiinfection, pulmonary immune dysfunction, and the onset/ toneally with saline on Days 0 and 14 and challenged with nebulized progression of asthma.
saline on Days 24, 25, and 26 as described above.
Our previous studies in the mouse demonstrated that the Ear gene family is comparatively large relative to humans, and includes eleven genes as well as two pseudogenes IL-4/IL-13 Instillation (23, 25) . Moreover, the presence of Ear transcripts in the Lyophilized mouse recombinant IL-13 was a kind gift of Dr. Debra lungs of naive animals suggested that the expression of Donaldson and Dr. Joseph Sypek (Genetics Institute, Boston, MA) these genes may not necessarily be restricted to eosinophils and recombinant IL-4 was purchased from Roche (Indianapolis, (25, 32) . In this study, we demonstrate that the alveolar IN) . Both were dissolved in PBS containing 0.1% bovine serum macrophage is another cellular source of Ears in the lungs of mice: eosinophils recruited to the lung (sequestered, preformed Ear proteins representing several [5] [6] 
Isolation of cDNA Clones and Sequence Analysis
with the use of reflected-light. Total RNA was isolated from lung tissue and used to make cDNA as described above. The cDNA was amplified using primers (forward primer: 5Ј-CGACTTTGTCTCCTGCTG-3Ј and reverse primer: 5Ј-
Alveolar Macrophage Isolation and Culturing Conditions
TGTCCCATCCAAGTGAAC-3Ј) capable of amplifying all Ear genes (25). Double stranded cDNA products were cloned into the Lungs were lavaged two times with 0.5 ml PBS (total volume ϭ 1 pcDNA2 vector (Invitrogen, Carlsbad, CA) and sequencing reacml) and the recovered fluid was centrifuged at 4ЊC (500 ϫ g; 10 tions of plasmid templates were performed using cycle-sequencing min), generating a BAL cell pellet and a cell-free supernatant. The reactions and analyzed using an Applied Biosystem model 373A cell pellets were resuspended in RPMI 1640 supplemented with 2% automated DNA sequencer (Perkin-Elmer).
heat-inactivated FCS, L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 g/ml) (all supplements were from Gibco, Carlsbad, CA). Differential cell counts were performed by counting at least 400 cells on cytocentrifuged preparations (Cytospin 2; Shan-
BAL and RNase Activity Assay
don-Lipshaw), stained with the Diff-Quik Stain Set (Dade Behring; Lungs were lavaged two times with 0.5 ml PBS (i.e., total volume ϭ Newark, DE). The cells were plated in 6 well dishes, allowed to 1 ml). The recovered BALFs were pooled and centrifuged at 4ЊC
adhere to the dishes for 2 h, and the nonadherent cells were removed. (500 ϫ g; 10 min) generating a BAL cell pellet and a cell-free
The adherent cells (Ͼ 99% alveolar macrophages) were removed supernatant (BALF). The amount of protein present in the BALF using a cell scraper and total RNA was isolated as described above. was determined using the BCA Protein Assay Reagent (Pierce, Rockford, IL). The BALF was then stored at Ϫ80ЊC. RNase activity in the BALF was assessed using the RNaseAlert QC System (AmStatistical Analysis bion). A reaction mixture containing 400 ng total BAL-derived protein, RNaseAlert buffer, and 200 nM fluorescent RNA substrate, Data presented are the means (Ϯ SE). Statistical analysis was perin a total reaction volume of 500 l, was equilibrated at 37ЊC for formed on parametric data using Student t tests with differences 10 min. The samples were excited at 490 nm and the emission at between means considered significant when P Ͻ 0.05. 520 nm was recorded using a fluorescent spectrophotomer (F-4500; Hitachi, San Jose, CA). The RNase activity of each sample was
Results
determined from a standard curve of the RNase activity generated with RNase A (Cat. #2271; Ambion). This assay is linear over a The level of Ear expression in the lungs of saline and OVAtreated mice was assessed by northern blot ( Figure 1A ) using an Ear2 cDNA sequence at sufficiently low hybridization/ Immunohistochemistry and In Situ Hybridization wash criteria as to allow cross-reactivity with other members
OVA Sensitization and Challenge Results in the Increased
The lungs of sacrificed mice were gravity-inflated (i.e., constant of the Ear subgroup of genes (Ͼ 70% nucleotide identity).
pressure) with 0.5 ml of 4% paraformaldehyde, fixed overnight at Significant steady-state levels of Ear transcripts were detected 4ЊC, dehydrated, and embedded in paraffin. Sections (4 m) were processed for either confocal microscopy using antibodies specific in both saline and OVA-treated lungs; however, OVA sensitifor eosinophil secondary granule proteins (i.e., major basic protein zation/challenge results in a substantial increase in Ear tran- [MBP] and Ears) or in situ hybridization using antisense radiolabeled script accumulation relative to saline-treated mice.
RNA probes for Ear2 and Ear11.
The Ear transcripts present in the lungs of saline and only transcripts from Ear2 and Ear11 gene were detected in
In situ hybridization with Ear subgroup specific probes. In situ hybridization was performed as described by Lee and colleagues the lungs of OVA-treated mice, representing 58% and 42%, from either saline-or OVA-treated groups were identified as eosinophils (i.e., the MBP ϩ cells), demonstrating that significant levels of Ears are sequestered only in pulmonary eosinophils. respectively. It is noteworthy that these sequencing data dem-
The presence of a secretory signal peptide in the Ears onstrate that in addition to the appearance of Ear11 tran-(23) suggested that other cells in the lung may produce Ears scripts, OVA sensitization/challenge likely leads to the enthat are secreted and thereby escape immunohistochemical hanced accumulation of pulmonary Ear2 transcripts. That is, detection with anti-Ear antibodies. To identify such sources, despite a nominal drop in Ear2 relative transcript prevalence in situ hybridization with probes specific for either Ear1/ (i.e., 87% versus 58%), the 5-to 10-fold increase in absolute Ear2 or Ear11 (i.e., the only identified Ears expressed in Ear transcript accumulation observed in Figure 1A shows the lung) was employed ( Figure 4) . In situ hybridization that the OVA treatment led to a significant increase in Ear2 using an Ear1/Ear2-specific probe demonstrated the prestranscript accumulation in the lung. Consistent with the seence of numerous positive staining cells in the lungs of both quencing of these Ear RT-PCR amplicons, the Ear1/2/3/8/9/ saline-and OVA-treated mice. In contrast, Ear11 tran-10 subgroup primer set detects the presence of transcripts in scripts were not observed in the lungs of saline-treated the lungs of both saline-and OVA-treated mice, whereas mice and were detected only after OVA challenge. Higher primers specific for the Ear5/11 subgroup detects Ear11 tranmagnification and differential staining of these sections (inscripts only following OVA sensitization/challenge ( Figure  sets of Figure 4 ) demonstrated that all of the cells hybridiz-1B). Significantly, these data show that even at the sensitivity ing to the Ear1/Ear2/Ear11 probes were alveolar macroafforded by PCR, Ear11 transcripts were not detected in phages. Surprisingly, none of the eosinophils present in the saline-treated mice.
lung exhibited evidence of hybridization to any of the Ear BALF was isolated and the amount of RNase activity probes used. It is also noteworthy that no differences were was assayed to determine if the increase in pulmonary Ear evident in the number of Ear1/Ear2-positive macrophages transcript levels in response to OVA was accompanied by a present in either the saline-or OVA-treated mouse lungs. concomitant increase in airway RNase activity. The data In addition, unlike Ear1/Ear2 expression, which occurred demonstrate that considerable RNase activity is present in in most, and perhaps all, alveolar macrophages, Ear11 tranthe airway lumen at homeostasis, consistent with the constiscripts appeared to accumulate only in a subset of macrotutive expression of Ear1 and Ear2 (Figure 2 cloned RT-PCR amplicons demonstrated transcript distriexpression in naive mice. In situ hybridization of lung sections following instillation of either cytokine showed that, bution patterns equivalent to those observed in the lungs similar to OVA sensitization/challenge, alveolar macroof wild-type mice (data not shown). In contrast, the OVAphages were the cellular source of the induced Ear11 tranmediated induction of Ear11 transcript accumulation in the script accumulation in the lung (data not shown). These lung was not detected in mice deficient of either all T cells data were confirmed using RT-PCR of total RNA isolated (␣␤ Ϫ/Ϫ , ␥␦ Ϫ/Ϫ ) or CD4 ϩ cells (i.e., in addition to wild-type from purified alveolar macrophages from these mice mice, Ear11 transcripts were present only in OVA-treated ( Figure 7A ). As observed in saline-and OVA-treated mice, CD8 Ϫ/Ϫ animals).
Ear1 and Ear2 transcripts were detected in alveolar macroInduction of Ear11 in the Lung Is Mediated by the T H 2 phages recovered from both IL-13-and vehicle (0.1%BSA Cytokines IL-4 and/or IL-13, but Not IL- 5 in PBS)-treated mice. Ear11 transcript accumulation, however, occurred only in macrophages isolated from the lungs The dependence of Ear11 expression in the lung on the of mice administered intratracheal IL-13. Moreover, the presence of T cells, particularly CD4 ϩ cells, suggested that induction of Ear expression was also accompanied by an this expression was tightly linked to T H 2-associated inincrease in RNase activity in the lungs of IL-13-treated flammatory signals and perhaps T H 2 cytokines themselves. mice ( Figure 7B) . Significantly, the magnitude of the inConsistent with this hypothesis, intratracheal administracrease (1.7-fold) in RNase activity (relative to vehicle/saline tion of either IL-4 or IL-13 into naive mice resulted in the controls) was comparable to the increase observed in the induction of the Ear11 gene independent of OVA sensitiza-BALF of OVA-treated wild-type mice (Figure 2 versus tion/challenge ( Figure 6A ). Interestingly, RT-PCR of RNA Figure 7B ). isolated from the lungs of OVA-sensitized/challenged IL-5 Ϫ/Ϫ mice demonstrated that OVA-induced expression of
Discussion
Ear11 is not dependent on IL-5 and occurs in the absence of this cytokine ( Figure 6B) .
The identification of a conserved subfamily of RNases (i.e., Ears) that were abundant components of the proteins stored
IL-13 Elicits De Novo Expression of Ear11 in Alveolar
in mouse eosinophil secondary granules had led to the hyMacrophages of Naive Mice pothesis that these proteins were eosinophil-specific mediaAdministration (intratracheally) of either IL-4 or IL-13 was tors of effector function requiring RNase activity(ies) (23, 25). In particular, the concomitant pulmonary eosinophilia necessary and sufficient for the induction of Ear11 gene occurring following allergen provocation suggested that lenge in mice provide a significant correlative relationship in support of pulmonary eosinophils (i.e., Ears sequestered Ears may have a role(s) in the onset/progression of allergic respiratory inflammation. Moreover, the recent demonstrain secondary granules) as the source of airway RNase activity. However, several observations suggest that alveolar tion of the viricidal activities associated with the human Ears, EDN and ECP, further suggested that eosinophil remacrophages are also a significant source of Ears in the lung: (i ) RT-PCR analyses demonstrated that the Ear gene cruitment to the lung may represent a host defense mechanism against single-stranded RNA viruses such as RSV expression in the lungs of naive mice (25) correlating with the presence of airway RNase activity occurred despite (29, 40).
The concurrent increases in BAL RNase activity and an exceedingly small resident eosinophil population in the lungs of these mice; (ii) in situ hybridization using Ear gene eosinophil recruitment following OVA sensitization/chal- ), CD4 ϩ cell-, or CD8 ϩ cell-deficient mice were performed using RT-PCR and primer sets specific for the Ear1/Ear2 or Ear11 subfamilies. Control reactions using Ear2 and Ear11 cDNA clones as template are included to verify the specificity of the primer sets and a GAPDH primer set is included as a control for the reverse transcription reactions.
probes demonstrated constitutive expression of several Ear genes in resident alveolar macrophages, and not eosinophils, of naive mice. Moreover, allergen provocation led to the enhanced accumulation of Ear2 transcipts and the de EPO [41] ), as well as immunohistochemistry studies using Ear and MBP-specific antibodies, demonstrated that a significant amount of eosinophil degranulation does not occur as a consequence of OVA provocation; thus, although eo-IL-4 or IL-13 suggests that allergen-induced Ear11 expression is mediated by one or more receptors recognizing these sinophils may sequester significant amounts of several Ear proteins, these proteins are not necessarily released followcytokines, including the IL-4/IL-13 common receptor IL-4R␣/␥ c (42) as well as potentially unique IL-13 specific reing allergen provocation; and (vi) repeated attempts to detect Ear11 transcripts or protein in purified mouse eosinoceptors (43, 44) . The presence of IL-4R␣ receptors on macrophages is consistent with this hypothesis (42, 45, 46) and phils have been futile (unpublished data). Collectively, these data indicate that although eosinophils are capable suggests that in addition to previously demonstrated changes in T H 2-activated inflammatory macrophages, inof expressing Ear genes, and even storing Ear proteins in their secondary granules, the eosinophil does not seem cluding an increased capacity for endocytic clearance and changes in cytokine expression profiles (45) , IL-4/IL-13 eliccapable of releasing these proteins into the airway lumen (i.e., degranulation). Instead, these data provide a signifiits de novo changes in gene expression that lead to the release of Ear proteins into the airway lumen. Furthermore, cant and definitive body of evidence that alveolar macrophages express Ear genes and implicates the alveolar macroit appeared that only a subset of alveolar macrophages expressed Ear11 in response to IL-4/IL-13, demonstrating phage as an alternative, and likely significant, source of pulmonary Ear expression in the mouse.
that IL-4/IL-13 mediate pulmonary changes that are not ubiquitous. The random spatial distribution of Ear11-expresThe appearance and accumulation of Ear11 transcripts in alveolar macrophages from naive mice administered either sing macrophages within the lung suggests that additional the inflammation and epithelial cell death associated with pulmonary allergen challenge would necessitate the expansion of this pathway (i.e., the OVA-induced increase of Ear2 transcript accumulation and the appearance of Ear11 transcripts). An extrapolation of this hypothesis is that any destructive pulmonary provocation would necessitate increased Ear gene expression. However, the induction of pulmonary Ear expression appears limited to allergen challenge and does not occur following exposure to LPS (data not shown), suggesting the unlikelihood of a nonspecific clearance mechanism. The recent demonstration that the human Ear genes, ECP and EDN, are capable of killing single-stranded RNA viruses (e.g., RSV) in situ (29, 30, 40) provides a provocative rationale for the expression of Ears in the airway lumen: alveolar macrophage-derived Ear expression is an innate host defensive mechanism against respiratory viral infection. Thus, the constitutive, yet regulated, expression of Ear1/Ear2 provides an organ-specific innate defense against low-level viral exposure. In this model, IL-4/IL-13-mediated expression of Ear11 during allergen challenge may occur as a consequence of eliciting immune pathways that are common with acquired host defense mechanisms against certain viral infections. A logical extension of this hypothesis is that viral infection would also induce pulmonary Ear gene expression and, indeed, our preliminary experiments using a viral model in the mouse demonstrates that RSV infection leads to the de novo expression of Ear11 by alveolar macrophages (S. A. Cormier and coworkers, unpublished results). It is noteworthy that the "scavenger hypothesis" and the "antiviral model" are not mutually exclusive and that antiviral functions of Ears may be a selectively may be a rodent-specific mechanism that has occurred as a consequence of differences in eosinophil effector functions between mammalian species. For example, in humans, eosinophil degranulation is associated with pulmonary provoimmune microenvironmental cues are likely required for cation (47) (48) (49) , thereby providing a strategically important expression of Ear11.
delivery mechanism for large quantities of Ear proteins to The expression of Ear1/Ear2 in apparently all alveolar the airway lumen. In the mouse, however, overt degranulamacrophages suggests that these RNases are a part of a tion of eosinophils in the lung following provocation is not mechanism(s) by which lung homeostasis is maintained.
observed (37, 41, 49, 50) . Thus, if the antiviral and/or clearThe enhanced accumulation of Ear2 transcripts and the de ance functions provided by airway Ears is selectively advannovo appearance of mRNAs representing Ear11 following tageous in both species, the mouse may have evolved an allergen provocation may be necessary to regain lung hoalternative strategy to provide these proteins in light of meostatsis. Alternatively, the increased presence of Ears, adaptive pressures associated with changing eosinophil efincluding the appearance of a unique RNase (i.e., Ear11) fector functions. The evolutionary origin(s) of leukocytemay be serving a novel and possibly unknown function in derived Ear gene expression itself remain(s) equally unthe lung. A "housekeeping" explanation for Ear expression clear. The induced expression of specific RNases in human is summarized by a scavenger hypothesis: Ears are expressed (51, 52) and mouse macrophages (51, 52) , as well as eosinoby alveolar macrophages as a clearance pathway degrading phils from both species (23, 25, 29, 40, 53, 54), suggests total RNA released from dying epithelial cells or from microeither that expression evolved independently in multiple organisms attempting to colonize the lung. In this hypothesis, leukocytes or occurred early in evolution (i.e., predating the nominal, yet constitutive, expression of Ear1/Ear2 is necesorigin of leukocytic subtypes) and has since been retained in sary to remove ever-present cellular debris that would otherwise accumulate and block the airway lumen. In addition, multiple cell types. Irrespective of defining these origins, 
